Navigation Links
Air Methods' Preliminary 1st Qtr. Results Exceed Expectations
Date:4/23/2009

All Key Measures Are In-Line With or Exceed Expectations

DENVER, April 23 /PRNewswire-FirstCall/ -- Air Methods Corporation (Nasdaq: AIRM), the largest air medical transportation company in the world, reported that preliminary first quarter 2009 earnings exceed expectations. Expected earnings improvement is attributed to better-than-anticipated patient transports in March, improved reimbursement for community-based transports, and lower maintenance and fuel expense.

Total community-based patient transports were 9,432 during the current-year quarter. Patients transported for community bases in operation greater than one year (Same-Base Transports) decreased 418 transports or 4%, while weather cancellations for these same bases decreased by 758 transports compared with the prior-year quarter. During the month of March, Same-Base Transports increased by 6 transports or less than 1%, while weather cancellations for these same bases decreased by 94 transports compared with the prior-year month.

Preliminary net revenue per community-based transport for the first quarter of 2009 was in-line with management's expectations and reflects significant improvement over the prior-year first quarter result of $6,622 per transport, as well as an increase over the fourth quarter 2008 result of $7,156 per transport.

Preliminary maintenance expense reflects a $2.8 million reduction compared with the prior-year quarter. Maintenance cost per flight hour decreased $43 per hour, or 7% compared with the prior-year quarterly result of $610 per hour. Preliminary fuel expense decreased by $1.4 million compared with the prior-year quarter, while fuel costs per community-based patient transport decreased by $98 per transport, or 28% from $351 in the prior-year period.

The Company noted that these preliminary results are subject to final quarter-end closing and review procedures and are therefore subject to change.

Aaron Todd, CEO, stated, "We are pleased to see a return to earnings growth for the first quarter of 2009. We are especially encouraged by the return to historical levels of demand for service during the month of March. Efforts to reduce maintenance costs through fleet rejuvenation and utilization of more efficient single-engine aircraft are now generating returns on these investments. The quarter has also benefited from greatly improved financial performance within our Products Division as a result of increased backlog and due to improved operating performance within our hospital-based operations."

The Company will report financial results for the first quarter ended March 31, 2009 after the close of the market on Thursday, May 7, 2009. The Company has scheduled a conference call for Thursday, May 7, 2009 at 4:15 p.m. Eastern to discuss these results. Interested parties can access the call by dialing (877) 883-0656 (domestic) or (706) 643-8826 (international) or by accessing the web cast at www.airmethods.com. A replay of the call will be available at (800) 642-1687 (domestic) or (706) 645-9291 (international), access number 96724635 for 3 days following the call and the web cast can be accessed at www.airmethods.com for 30 days.

Air Methods Corporation (www.airmethods.com) is a leader in emergency air medical transportation and medical services. The Hospital Based Services Division is the largest provider of air medical transport services for hospitals. The Community Based Services Division is the largest community-based provider of air medical services. The Products Division specializes in the design and manufacture of aeromedical and aerospace technology. The Company's fleet of owned, leased or maintained aircraft features over 300 helicopters and fixed wing aircraft.

Forward Looking Statements: This news release includes certain forward-looking statements, which are subject to various risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including but not limited to the size, structure and growth of the Company's air medical services and products markets; the collection rates for patient transports; the continuation and/or renewal of air medical service contracts; the acquisition of profitable Products Division contracts and other flight service operations; the successful expansion of the community-based operations; and other matters set forth in the Company's public filings.

CONTACTS: Aaron D. Todd, Chief Executive Officer, (303) 792-7413. Please contact Christine Clarke at (303) 792-7579 to be included on the Company's fax and/or mailing list.


'/>"/>
SOURCE Air Methods Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Air Methods Announces Year 2008 Financial Results and Provides First Quarter 2009 Update
2. Air Methods to Report Fourth Quarter and Fiscal Year 2008 Financial Results on Tuesday, March 10, 2009
3. Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention
4. Early Detection Methods for Pancreatic Cancer Urgently Needed: A Statement From the Pancreatic Cancer Action Network
5. National Patient Advocate Foundation Founder Testifies Before U.S. Senate Health Committee on Methods to Improve Healthcare Quality and Patient Outcomes
6. Air Methods Provides 4th Quarter Update
7. Activator Methods Introduces Web-Based Seminar Program
8. SpectraScience Awarded U.S. Patent 7,469,160 for Its Unique Methods and Apparatus for Evaluating Image Focus
9. Immunology Center will continue to drive standard methods, better science
10. UC San Diego scientists developing brain imaging methods for studying natural human behavior
11. SpectraScience Awarded U.S. Patent 7,459,696 for its Unique Methods of Calibrating Spectral Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: